Delivery Order SPE2DB20D1004-SPE2DB24FE9Z4

Award Date 12/6/23
Potential Completion Date 12/7/23
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,094.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of MULTAQ 400 MG TABLET 60S, a medical product. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $8,614.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $2,613.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 7, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,831.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price (FFP) pricing type, and the ultimate completion date is January 14, 2025. The contract covers the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the DLA. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,111.71 firm fixed-price delivery order contract is for the supply of 4566542292 MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,479.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product MULTAQ 400 MG TABLET 60S, with a completion date of December 17, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,483.56, is a Firm Fixed Price Delivery Order to supply MULTAQ 400 MG TABLET 60S to the DLA. The contract has an ultimate completion date of December 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,614.25 firm fixed-price delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023 and was awarded on October 10, 2023. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,895.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of December 6, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. The contract award is not designated as a set-aside and is part of a larger Indefinite...
This federal contract award, valued at $8,007.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a performance period through December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FE9Z4
    Delivery Order

This federal contract award, valued at $3,747.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the delivery of 4563018350 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 7, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was competitively awarded.

Generated 2/27/25, 11:11 AM